Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

Results: 1 to 20 of 46

1.

Mobile DNA in cancer. Extensive transduction of nonrepetitive DNA mediated by L1 retrotransposition in cancer genomes.

Tubio JM, Li Y, Ju YS, Martincorena I, Cooke SL, Tojo M, Gundem G, Pipinikas CP, Zamora J, Raine K, Menzies A, Roman-Garcia P, Fullam A, Gerstung M, Shlien A, Tarpey PS, Papaemmanuil E, Knappskog S, Van Loo P, Ramakrishna M, Davies HR, Marshall J, Wedge DC, Teague JW, Butler AP, Nik-Zainal S, Alexandrov L, Behjati S, Yates LR, Bolli N, Mudie L, Hardy C, Martin S, McLaren S, O'Meara S, Anderson E, Maddison M, Gamble S; ICGC Breast Cancer Group; ICGC Bone Cancer Group; ICGC Prostate Cancer Group, Foster C, Warren AY, Whitaker H, Brewer D, Eeles R, Cooper C, Neal D, Lynch AG, Visakorpi T, Isaacs WB, van't Veer L, Caldas C, Desmedt C, Sotiriou C, Aparicio S, Foekens JA, Eyfjörd JE, Lakhani SR, Thomas G, Myklebost O, Span PN, Børresen-Dale AL, Richardson AL, Van de Vijver M, Vincent-Salomon A, Van den Eynden GG, Flanagan AM, Futreal PA, Janes SM, Bova GS, Stratton MR, McDermott U, Campbell PJ.

Science. 2014 Aug 1;345(6196):1251343. doi: 10.1126/science.1251343.

PMID:
25082706
[PubMed - indexed for MEDLINE]
2.

MDM2 SNP309 and risk of endometrial cancer.

Knappskog S, Lønning PE.

Tumour Biol. 2014 Aug;35(8):7285-6. doi: 10.1007/s13277-014-2244-y. Epub 2014 Jun 26. No abstract available.

PMID:
24964960
[PubMed - in process]
3.

TP53 status predicts long-term survival in locally advanced breast cancer after primary chemotherapy.

Eikesdal HP, Knappskog S, Aas T, Lønning PE.

Acta Oncol. 2014 Jun 9:1-9. [Epub ahead of print]

PMID:
24909504
[PubMed - as supplied by publisher]
4.

MDM2 SNP309 and risk of cervical cancer.

Knappskog S, Lønning PE.

Tumour Biol. 2014 Jul;35(7):6185-6. doi: 10.1007/s13277-014-1910-4. Epub 2014 Apr 17. No abstract available.

PMID:
24740562
[PubMed - in process]
5.

Association of a germline copy number polymorphism of APOBEC3A and APOBEC3B with burden of putative APOBEC-dependent mutations in breast cancer.

Nik-Zainal S, Wedge DC, Alexandrov LB, Petljak M, Butler AP, Bolli N, Davies HR, Knappskog S, Martin S, Papaemmanuil E, Ramakrishna M, Shlien A, Simonic I, Xue Y, Tyler-Smith C, Campbell PJ, Stratton MR.

Nat Genet. 2014 May;46(5):487-91. doi: 10.1038/ng.2955. Epub 2014 Apr 13.

PMID:
24728294
[PubMed - indexed for MEDLINE]
6.

Effects of SNP variants in the 17β-HSD2 and 17β-HSD7 genes and 17β-HSD7 copy number on gene transcript and estradiol levels in breast cancer tissue.

Straume AH, Knappskog S, Lønning PE.

J Steroid Biochem Mol Biol. 2014 Sep;143:192-8. doi: 10.1016/j.jsbmb.2014.02.003. Epub 2014 Feb 18.

PMID:
24560990
[PubMed - in process]
Free Article
7.

Inverse regulation of EGFR/HER1 and HER2-4 in normal and malignant human breast tissue.

Flågeng MH, Knappskog S, Haynes BP, Lønning PE, Mellgren G.

PLoS One. 2013 Aug 22;8(8):e74618. doi: 10.1371/journal.pone.0074618. eCollection 2013.

PMID:
23991224
[PubMed - indexed for MEDLINE]
Free PMC Article
8.

CXXC5 (retinoid-inducible nuclear factor, RINF) is a potential therapeutic target in high-risk human acute myeloid leukemia.

Astori A, Fredly H, Aloysius TA, Bullinger L, Mansat-De Mas V, de la Grange P, Delhommeau F, Hagen KM, Récher C, Dusanter-Fourt I, Knappskog S, Lillehaug JR, Pendino F, Bruserud Ø.

Oncotarget. 2013 Sep;4(9):1438-48.

PMID:
23988457
[PubMed - indexed for MEDLINE]
Free PMC Article
9.

Signatures of mutational processes in human cancer.

Alexandrov LB, Nik-Zainal S, Wedge DC, Aparicio SA, Behjati S, Biankin AV, Bignell GR, Bolli N, Borg A, Børresen-Dale AL, Boyault S, Burkhardt B, Butler AP, Caldas C, Davies HR, Desmedt C, Eils R, Eyfjörd JE, Foekens JA, Greaves M, Hosoda F, Hutter B, Ilicic T, Imbeaud S, Imielinski M, Jäger N, Jones DT, Jones D, Knappskog S, Kool M, Lakhani SR, López-Otín C, Martin S, Munshi NC, Nakamura H, Northcott PA, Pajic M, Papaemmanuil E, Paradiso A, Pearson JV, Puente XS, Raine K, Ramakrishna M, Richardson AL, Richter J, Rosenstiel P, Schlesner M, Schumacher TN, Span PN, Teague JW, Totoki Y, Tutt AN, Valdés-Mas R, van Buuren MM, van 't Veer L, Vincent-Salomon A, Waddell N, Yates LR; Australian Pancreatic Cancer Genome Initiative; ICGC Breast Cancer Consortium; ICGC MMML-Seq Consortium; ICGC PedBrain, Zucman-Rossi J, Futreal PA, McDermott U, Lichter P, Meyerson M, Grimmond SM, Siebert R, Campo E, Shibata T, Pfister SM, Campbell PJ, Stratton MR.

Nature. 2013 Aug 22;500(7463):415-21. doi: 10.1038/nature12477. Epub 2013 Aug 14. Erratum in: Nature. 2013 Oct 10;502(7470):258. Imielinsk, Marcin [corrected to Imielinski, Marcin].

PMID:
23945592
[PubMed - indexed for MEDLINE]
Free PMC Article
10.

Outcome after surgery for primary hyperaldosteronism may depend on KCNJ5 tumor mutation status: a population-based study from Western Norway.

Arnesen T, Glomnes N, Strømsøy S, Knappskog S, Heie A, Akslen LA, Grytaas M, Varhaug JE, Gimm O, Brauckhoff M.

Langenbecks Arch Surg. 2013 Aug;398(6):869-74. doi: 10.1007/s00423-013-1093-2. Epub 2013 Jun 19.

PMID:
23778974
[PubMed - indexed for MEDLINE]
11.

Low BRAF and NRAS expression levels are associated with clinical benefit from DTIC therapy and prognosis in metastatic melanoma.

Birkeland E, Busch C, Berge EO, Geisler J, Jönsson G, Lillehaug JR, Knappskog S, Lønning PE.

Clin Exp Metastasis. 2013 Oct;30(7):867-76. doi: 10.1007/s10585-013-9587-4. Epub 2013 May 15.

PMID:
23673558
[PubMed - indexed for MEDLINE]
Free PMC Article
12.

MDM2 SNP309 and risk of endometrial cancer.

Knappskog S, Lønning PE.

Pol J Pathol. 2013 Apr;64(1):69-70. No abstract available.

PMID:
23625604
[PubMed - indexed for MEDLINE]
13.

Mapping genetic alterations causing chemoresistance in cancer: identifying the roads by tracking the drivers.

Lønning PE, Knappskog S.

Oncogene. 2013 Nov 14;32(46):5315-30. doi: 10.1038/onc.2013.48. Epub 2013 Mar 11. Review.

PMID:
23474753
[PubMed - indexed for MEDLINE]
14.

Functional characterisation of p53 mutants identified in breast cancers with suboptimal responses to anthracyclines or mitomycin.

Berge EO, Huun J, Lillehaug JR, Lønning PE, Knappskog S.

Biochim Biophys Acta. 2013 Mar;1830(3):2790-7.

PMID:
23246812
[PubMed - indexed for MEDLINE]
Free Article
15.

Chemosensitivity and p53; new tricks by an old dog.

Lønning PE, Knappskog S.

Breast Cancer Res. 2012 Nov 6;14(6):325. doi: 10.1186/bcr3326.

PMID:
23131146
[PubMed - in process]
Free PMC Article
16.

Effect of the MDM2 promoter polymorphisms SNP309T>G and SNP285G>C on the risk of ovarian cancer in BRCA1 mutation carriers.

Bjørnslett M, Knappskog S, Lønning PE, Dørum A.

BMC Cancer. 2012 Oct 5;12:454. doi: 10.1186/1471-2407-12-454.

PMID:
23039163
[PubMed - indexed for MEDLINE]
Free PMC Article
17.

Re: Murine double minute 2 promoter SNP309 polymorphism and prostate cancer risk: a meta-analysis.

Knappskog S.

Int J Urol. 2012 Oct;19(10):966. doi: 10.1111/j.1442-2042.2012.03108.x. Epub 2012 Jul 30. No abstract available.

PMID:
22846160
[PubMed - indexed for MEDLINE]
18.

MDM2 promoter SNP344T>A (rs1196333) status does not affect cancer risk.

Knappskog S, Gansmo LB, Romundstad P, Bjørnslett M, Trovik J, Sommerfelt-Pettersen J, Løkkevik E; Norwegian Breast Cancer Group trial NBCG VI, Tollenaar RA, Seynaeve C, Devilee P, Salvesen HB, Dørum A, Hveem K, Vatten L, Lønning PE.

PLoS One. 2012;7(4):e36263. doi: 10.1371/journal.pone.0036263. Epub 2012 Apr 30.

PMID:
22558411
[PubMed - indexed for MEDLINE]
Free PMC Article
19.

Low expression levels of ATM may substitute for CHEK2 /TP53 mutations predicting resistance towards anthracycline and mitomycin chemotherapy in breast cancer.

Knappskog S, Chrisanthar R, Løkkevik E, Anker G, Østenstad B, Lundgren S, Risberg T, Mjaaland I, Leirvaag B, Miletic H, Lønning PE.

Breast Cancer Res. 2012 Mar 15;14(2):R47.

PMID:
22420423
[PubMed - indexed for MEDLINE]
Free PMC Article
20.

P53 and its molecular basis to chemoresistance in breast cancer.

Knappskog S, Lønning PE.

Expert Opin Ther Targets. 2012 Mar;16 Suppl 1:S23-30. doi: 10.1517/14728222.2011.640322. Epub 2012 Feb 8. Review.

PMID:
22313396
[PubMed - indexed for MEDLINE]

Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Loading ...
Write to the Help Desk